Drugs / Anti-3-[(18)F]FACBC
Anti-3-[(18)F]FACBC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01502670 | May 2009 → Jun 2012 | lung cancer | Emory University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-3-[(18)F]FACBC | “Anti-3-[(18)F]FACBC is a synthetic amino acid positron emission tomography (PET) radiotracer with utility in detection of prostate carcinoma and brain tumors and has also been...” PMID 23595643 ↗ Oct 2013 |
| Known as | Anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid | “Anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F]FACBC) is a synthetic amino acid positron emission tomography (PET) radiotracer” PMID 23595643 ↗ Oct 2013 |
| Modality | Diagnostic / imaging agent | “Anti-3-[(18)F]FACBC is a synthetic amino acid positron emission tomography (PET) radiotracer” PMID 23595643 ↗ Oct 2013 |
| Route | Intravenous | “after IV injection of 214.6-384.8MBq of anti-3-[(18)F]FACBC” PMID 23595643 ↗ Oct 2013 |